The role of plasminogen activators in metastasis. 1983

R Ng, and J A Kellen

UI MeSH Term Description Entries
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010960 Plasminogen Activators A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. Extrinsic Plasminogen Activators,Plasminogen Activator,Uterine-Tissue Plasminogen Activator,Uterine Tissue Plasminogen Activator
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Ng, and J A Kellen
January 1991, International journal of dermatology,
R Ng, and J A Kellen
January 1983, Ukrainskii biokhimicheskii zhurnal (1978),
R Ng, and J A Kellen
April 2002, Biochemical Society transactions,
R Ng, and J A Kellen
January 1986, Problemy endokrinologii,
R Ng, and J A Kellen
January 1996, Current topics in microbiology and immunology,
R Ng, and J A Kellen
June 2002, Annales de cardiologie et d'angeiologie,
R Ng, and J A Kellen
September 1985, International journal of dermatology,
Copied contents to your clipboard!